Tamar Kahn is a Health & Science Correspondent at Business Day. She covers a range of topics including health, education, and the healthcare system, with a focus on consumer health, public health, and educational policy. Tamar's work has been featured in prominent publications such as Sowetan, Sunday Times, and Financial Mail, showcasing her expertise in health and wellness reporting.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
South Africa (National)
Not enough data
Tamar Kahn's coverage primarily focuses on health-related issues within South Africa, with a particular emphasis on government announcements and legal policy regulation. She appears to be interested in stories related to the National Health Insurance (NHI), healthcare funding, vaccine contracts, lobbying efforts, budget cuts, court cases in the context of public health issues such as mental health, HIV/AIDS prevention, and human rights.
Given this focus, individuals or organizations with expertise in public health policy and advocacy within South Africa may find success reaching out to Tamar. Specifically relevant would be those who can provide insight into government policies related to healthcare funding and NHI implementation. Additionally, sources who have data-driven insights or are involved in lobbying efforts around these topics may also appeal to her reporting interests.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Black Pharmaceutical Industry Association chides health department's procurement policies
Advocacy group calls for transformation quotas and long-term supply contracts
Officials reject Cipla's claims of flawed process and collusive bidding
Kholeka Gcaleka demands swift action on funding model and service standards
Kholeka Gcaleka demands swift action on funding model and service standards
$450m lifeline comes with a catch as early-career grants are now excluded
By: Tamar Kahn
South Africa's pharmaceutical manufacturing industry has secured a commitment from senior government officials to jointly review the regulations governing private-sector medicine prices, which the sector has long complained are not applied in a clear and consistent manner.
By: Tamar Kahn
Health department agrees to work with industry on regulation and localisation
By: Tamar Kahn
Mzamo Buthelezi urges medical scheme to fight fraud, maintain member benefits
The injection has been shown to provide almost complete protection against HIV infection
